| Aug 1 |
Arbutus Biopharma Corporation (ABUS) Q2 2024 Earnings Call Transcript
|
| Aug 1 |
Arbutus cutting 40% of workforce to focus on phase 2 hepatitis b asset imdusiran
|
| Aug 1 |
Arbutus Biopharma (ABUS) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 1 |
Arbutus: Q2 Earnings Snapshot
|
| Aug 1 |
Arbutus Biopharma GAAP EPS of -$0.11 misses by $0.01, revenue of $1.73M misses by $0.03M
|
| Aug 1 |
Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
| Jul 31 |
Arbutus Biopharma Q2 2024 Earnings Preview
|
| Jul 23 |
Amgen, Garmin among relative market leaders poised to outperform in coming months: BTIG
|
| Jul 18 |
Arbutus to Report Second Quarter 2024 Financial Results and Provide Corporate Update
|
| Jul 5 |
Arbutus Biopharma: Focused On HBV With A Potentially Huge Litigation 'Wildcard'
|
